Reuse of single-use devices
This article was originally published in The Gray Sheet
Executive Summary
Senate Health Committee intends to hold a hearing on the contentious issue to gather information, possibly before the August congressional recess, according to committee staffers. As of late July 16, the committee had yet to receive FDA's response to its request for details regarding the agency's plans for regulating reprocessed single-use devices (1"The Gray Sheet" July 12, In Brief)
You may also be interested in...
Reuse of single-use devices
Senate Health Committee Chairman James Jeffords (R-Vt.) and panel member Bill Frist (R-Tenn.) request in a July 2 letter to FDA Commissioner Jane Henney that the agency provide by July 12 an explanation as to the "current activities...being taken by FDA to ensure that all reprocessed single-use devices are safe and effective for their intended use." The senators also ask FDA to explain its "future plans...to address this issue, including a detailed timeline for full implementation." The agency also is requested to specify whether it believes "new legislative authority is necessary for FDA to require" registration of and premarket submissions from device reprocessors. In addition, FDA is asked to supply the "total number" and a "complete list" of reprocessed, single-use devices
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.
Generic Or Innovator? Sandoz Sues CMS Over Potential Change In Rebate Classification
Sandoz argued against paying higher rebates for two of its drugs via the Centers for Medicare and Medicaid Services’ Medicaid drug rebate program in a US court six years after the suggestion was first made.